过去一年中添加的文章,按日期排序
O-01 Case report: Temozolomide treatment of refractory prolactinoma
AB Nekic, KZ Tomsic, D Kastelan… - JCEM Case …, 2024 - academic.oup.com
178 天前 - … Temozolomide (TMZ), an oral chemotherapeutic agent, … effective drug for refractory
pituitary adenomas or carcinomas. … Tumor histology was consistent with an atypical pituitary …
pituitary adenomas or carcinomas. … Tumor histology was consistent with an atypical pituitary …
P-57 A case of pituitary carcinoma treated with osilodrostat for severe Cushing's syndrome
OO Golounina, LY Rozhinskaya… - JCEM Case …, 2024 - academic.oup.com
178 天前 - … % of pituitary tumors. We present a case of a male subject with ACTH-secreting
pituitary … Postoperative chemotherapy adjuvant treatment with Temozolomide and Carboplatin …
pituitary … Postoperative chemotherapy adjuvant treatment with Temozolomide and Carboplatin …
Aggressive and Metastatic Pituitary Neuroendocrine Tumors: Therapeutic Management and Off-Label Drug Use
P Iglesias - Journal of Clinical Medicine, 2023 - mdpi.com
197 天前 - … Temozolomide (TMZ) is now recognized as the primary medical treatment … (171
patients) of aggressive and metastatic pituitary tumors [9]. This study performed in 171 patients (…
patients) of aggressive and metastatic pituitary tumors [9]. This study performed in 171 patients (…
Research advances in treatment of aggressive pituitary adenomas
H LIU, W GU, Y MU - ACADEMIC JOURNAL OF …, 2023 - xuebao.301hospital.com.cn
207 天前 - … Temozolomide is recommended as first-line chemotherapy drug … aggressive pituitary
tumors, but it is only effective for partial patients. … patients with invasive pituitary adenomas. …
tumors, but it is only effective for partial patients. … patients with invasive pituitary adenomas. …
Endoscopy-assisted high anterior cervical approach in craniovertebral junction (CVJ) Pengfei Li, Kaixuan Wang, Hongming Ji, Gangli Zhang, Shengli Chen, Shiyuan …
Y Yang, C Lv - … Endoscopic Skull Base Tumor Surgery: from Basic …, 2023 - books.google.com
243 天前 - … sequencing of pituitary tumour tissues and TMZ-treated pituitary tumour cell
lines were … Temozolomide has broadspectrum anti-tumor activity. Temozolomide is a first-line …
lines were … Temozolomide has broadspectrum anti-tumor activity. Temozolomide is a first-line …
… and MSH2 immunohistochemistry status identifies a pituitary tumour subgroup with excellent progression free survival response to temozolomide: a single centre …
B Whitelaw, J Gilbert, C Ling, J Crane… - Endocrine …, 2023 - endocrine-abstracts.org
251 天前 - … response to temozolomide. … patients treated with temozolomide at our tertiary
pituitary service (2009-2022). We assessed the radiological (RECIST) response to temozolomide …
pituitary service (2009-2022). We assessed the radiological (RECIST) response to temozolomide …
An aggressive prolactinoma with orbital involvement and excellent response to treatment with temozolamide. A case report and systematic literature review
S Khalilova, C Gonzales - Endocrine Abstracts, 2023 - endocrine-abstracts.org
251 天前 - … response to temozolomide and a … the patient developed pituitary apoplexy which
required transphenoidal surgery (TSS). Histology showed Pit-1 positive pituitary adenoma with …
required transphenoidal surgery (TSS). Histology showed Pit-1 positive pituitary adenoma with …
An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or …
AS Alzahrani, A Bin Nafisah, M Alswailem… - Frontiers in …, 2023 - frontiersin.org
258 天前 - … pituitary tumors recommend this diagnosis to be considered “… patients with a
radiologically invasive tumour and unusually rapid tumour growth rate, or clinically relevant tumour …
radiologically invasive tumour and unusually rapid tumour growth rate, or clinically relevant tumour …
THU020 Bilateral Adrenal Hyperplasia (BAH): Undesirable Effect Of Glucocorticoid Receptor Competitive Antagonist (GRCAnt) In Cushing's Disease
A Canturk, C Villabona, A Kargi - Journal of the Endocrine …, 2023 - academic.oup.com
277 天前 - … BAH and potential factors explaining why this phenomenon might only occur in
selected patients, we also propose management of patients on long therapy with GRCAnts. …
selected patients, we also propose management of patients on long therapy with GRCAnts. …
SAT623 Everolimus For Treatment-refractory Prolactinomas
AL Lin, EB Geer, G Page-Wilson… - Journal of the …, 2023 - academic.oup.com
277 天前 - … , temozolomide, fails to provide tumor control. Methods: We reviewed an institutional
database of pituitary tumors for patients … , radiotherapy and temozolomide. In this cohort of …
database of pituitary tumors for patients … , radiotherapy and temozolomide. In this cohort of …